← back to search

Daniel Asarnow

University of Washington · US
Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Advanced Electron Microscopy Techniques and Applications, and Viral gastroenteritis research and epidemiology.
h-index
21
citations
4,016
works
65
NIH funding
primary concept
Biology
email

Recent publications

The computationally designed TRI2-2 miniprotein inhibitor protects against multiple SARS-CoV-2 Omicron variants
Communications Biology 2026cited by 1position: middledoi
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Cell 2025cited by 37position: middledoi
SARS-CoV-2 nsp1 mediates broad inhibition of translation in mammals
Cell Reports 2025cited by 4position: middledoi
Spike deep mutational scanning helps predict success of SARS-CoV-2 clades
Nature 2024cited by 118position: middledoi
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Nature Communications 2024cited by 19position: middledoi
A systematic search for RNA structural switches across the human transcriptome
Nature Methods 2024cited by 15position: middledoi
Recent advances in infectious disease research using cryo-electron tomography
Frontiers in Molecular Biosciences 2024cited by 7position: firstdoi
Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
Immunity 2024cited by 6position: middledoi
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
Cell 2021cited by 82position: firstdoi
Dispatched uses Na+ flux to power release of lipid-modified Hedgehog
Nature 2021cited by 37position: middledoi
Classifying liganded states in heterogeneous single-particle cryo-EM datasets
Microscopy 2021cited by 4position: middledoi
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
Science 2020cited by 808position: middledoi
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Science 2020cited by 466position: middledoi
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Nature Chemical Biology 2020cited by 114position: middledoi
Enhancing the signal-to-noise ratio and generating contrast for cryo-EM images with convolutional neural networks
IUCrJ 2020cited by 45position: middledoi
Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
PLoS Pathogens 2020cited by 21position: middledoi
Structural insight into TRPV5 channel function and modulation
Proceedings of the National Academy of Sciences 2019cited by 107position: middledoi
Structural Basis for Cholesterol Transport-like Activity of the Hedgehog Receptor Patched
Cell 2018cited by 245position: middledoi
Structure of the human TRPM4 ion channel in a lipid nanodisc
Science 2017cited by 284position: middledoi
Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis
PLoS ONE 2014cited by 68position: middledoi
Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis
BMC Genomics 2012cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yifan Cheng · Howard Hughes Medical Institute7 papers (2017–2024)David Veesler · Howard Hughes Medical Institute5 papers (2024–2025)Young‐Jun Park · Howard Hughes Medical Institute5 papers (2024–2026) · 4 papers (2024–2025)Jack Brown · University of Idaho3 papers (2024–2026)Melody G. Campbell · Fred Hutch Cancer Center3 papers (2017–2025)Cameron Stewart · University of Washington3 papers (2024–2025)Yunxiao Zhang · Scripps Research Institute2 papers (2018–2021)Brian M. Suzuki · University of California San Diego2 papers (2012–2014)Davide Corti · Vir Biotechnology (Switzerland)2 papers (2024–2024)M. Alejandra Tortorici · University of Washington2 papers (2024–2025)Joel Quispe · Seattle University2 papers (2024–2025) · 2 papers (2024–2025)David Julius · University of California System2 papers (2017–2019)Conor R. Caffrey · University of California San Diego2 papers (2012–2014)Kaitlin R. Sprouse · Howard Hughes Medical Institute2 papers (2024–2024)Philip A. Beachy · Stanford Medicine2 papers (2018–2021)Rahul Singh · University of Iowa2 papers (2012–2014) · 1 papers (2012–2012) · 1 papers (2024–2024)